FNYS
IDIX

First New York Securities’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

First New York Securities’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-17,900
Closed -$431K – 663
2014
Q2 		$431K Buy
+17,900
New +$187K 0.44% 37

First New York Securities's IDIX Position: Q3 2014 in Review

First New York Securities sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 17,900 shares — an estimated $431K sold.

First New York Securities first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $431K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • First New York Securities reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • First New York Securities sold 17,900 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $431K.
  • First New York Securities first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
  • First New York Securities's IDENIX PHARMACEUTICALS INC position peaked at $431K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on First New York Securities's 13F filing for Q3 2014, filed 16 Oct 2014.